News and Comments

Ariad’s (ARIA) ridaforolimus Brings Hope To Advanced Endometrial Cancer Patients.

  Monday, November 22, 2010

Endometrial cancer is the most common cancer of the female reproductive system. Advanced cases have virtually no effective treatments. Surgery, alone or in combination with radiation, chemotherapy, and/or hormonal therapy are good as initial therapy. In advanced stages, however, surgery has no role to play and chemotherapy has limited, if any, benefit.  More...


Recent Postings


Archive


Tags

Regeneron (REGN) AstraZeneca (AZN) GUARDIAN HEALTH Valeant Pharmaceuticals International (VRX) TOKAI (TKAOI) HALOZYME (HALO) ImmunoGen (IMGN) Multiple Myeloma Benlysta (belimumab) Tysabri Micromet (MITI) BIOMARIN (BMRN) Alnylam (ALNY) Amgen (AMGN) Pluristem (PSTI) ZALTRAP™ Telaprevir Prosensa (RNA) Dendreon (DNDN) Human Longevity (HLI) Idenix (IDIX) Ariad (ARIA) RenenxBio (RGNX) Sanofi (SNY) Zerenex GlaxoSmithKline (GSK) Theravance Bio Pharma (TBPH) Auspex (ASPX) galapagos (GLPG) Biogen Idec (BIIB) Human Genome Sciences (HGSI) JUNO (JUNO) Agenus (AGEN) ABBVIE (ABBV) Aimmune Therapeutics (AIMT) Bristol-Myers Squibb (BMY) Intercept (ICPT) Xoma (XOMA) Sequenom (SQNM) ADVENTRIX (ANX) Ziofpharm (ZIOP) Galena (GALE) Mirati Therapeutics (MRTX) Spike Therapeutics (ONCE) KERYX (KERX) NANTKWEST (NK) AERIE PHARMACEUTICALS IDERA (IDRA) OSI (OSIP) Trastuzumab-DM1 Incyte (INCY) AGOS (ARGS) CompuGen (CGEN) INNOVIVA (INVA) Intermune (ITMN) Roche (ROCHE) KITE (KITE) Exelixis (EXEL) Gilead (GILD) Sangamo (SGMO) NOVOCURE (NVCR) Advaxis (ADXS) Prolor Biotech (PBTH) Endometrial Cancer Vitae Pharmaceuticals (VTAE) Seattle Genetics (SGEN) Cytokinetics (CYTK) MODERNA REGULUS (RGLS) VANDA (VNDA) ARCA (ABIO) Roche (RHHBY) Ionis (IONS) Genentech Sanofi-Aventis (SAN) Illumina (ILMN) PTC Therapeutics (PTCT) Jazz Pharmaceuticals (JAZZ) Sarepta (SRPT) Theravance (THRX) SUNESIS PHARMACEUTICALS (SNSS) Biocryst (BCRX) Rapamune Global Cell Therapeutics (GBT) Inovio (INO) Bellicum (BLCM) Velcade (bortezomib) ACADIA (ACAD) Merck (MRK) Anadys (ANDS) Dynavax (DVAX) ISIS (ISIS) NEKTAR (NKTR)) Sanofi (SNA) Revlimid (lenolidamide) Array Pharmaceuticals (ARRY) Herceptin SYNTA (SNTA) Abbott Laboratories (ABT) Anacor (ANAC) Intrexon (XON) Editas (EDIT) Alder Biopharmaceuticals (ALDR) Elan (ELN) ARGOS (ARGS) Vertex (VRTX) Adaptimmune (ADAP) Ridaforolimus SERES THERAPEUTICS (MCRB) Agenus (AGEN C4 Therapeutics Onyx (ONXX)